Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002064832-25-000048
Filing Date
2025-12-03
Accepted
2025-12-03 17:02:10
Documents
1
Period of Report
2025-12-01

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3261
  Complete submission text file 0002064832-25-000048.txt   4693
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Issuer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ENANTA PHARMACEUTICALS, INC. 500 ARSENAL STREET WATERTOWN MA 02472
Business Address
Luu Brendan (Reporting) CIK: 0001842369 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35839 | Film No.: 251547247